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A b s t r a c t  
The aim of this study was to evaluate the anti-inflammatory and antioxidant efficacy of ethanolic 
extract of Bauhinia purpurea bark (EBP) in Sprague Dawley (SD) rats. Carrageenan induced paw 
edema and air pouch inflammation, arachidonic acid induced ear edema and complete freundÊs 
adjuvant (CFA) induced hematological alterations were studied in control and experimental rats. 
Administration of EBP (200mg, 400mg, 600 mg/kg body weight) showed a significant and dose 
dependent inhibition of paw edema and ear edema and also reversed the hematological alterations 
near to normalcy. DPPH assay and measurement of MDA levels showed potent antioxidant activity 
of EBP. With increase in concentration of EBP, improvement in walking scores of motility test 
confirmed the anti-inflammatory activity of EBP. Acute toxicity studies demonstrated non toxic nature 
of EBP even at higher doses. Together, our results demonstrate that EBP has potent anti-
inflammatory as well as potent antioxidant properties validating the folk medicinal use of this 
species. 
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Introduction 
Plants have been a valuable source of new bioactive factors and 
are considered as an efficient alternative strategy for the 
development of newer therapeutics. A good number of plants 
have been reported in traditional medicine to alleviate various 
inflammatory disorders. However, there has been little scientific 
effort to confirm these anecdotal. Bauhinia purpurea is a medium 
sized deciduous tree belongs to Leguminaceae family [1]. It is 
found in most types of vegetation ranging from evergreen lower 
lands, rain forests to mountain forests up to 2000-3000 m altitude 
and also in savanna scrub and dry deciduous forests to swamp 
forests on various soils. Bauhinia purpurea shows several 
pharmacological activities and research has been carried out on 
different parts of Bauhinia purpurea extract [2]. Previous reports 
state that the plant showed antidiarrhoeal [3], antispasmodic 
antimyocardial [4], antinociceptive, antioxidant and antipyretic [5-
6] antimicrobial, cytotoxic and antimycobacterial [7-8] wound 
healing [9] antinephrotoxicity [10] activities. Different parts of 
Bauhinia purpurea were reported to possess such phytochemicals 
as glycosides, flavanoids, saponins, triterpenoids, phenolic 
compounds, oxepins, fatty acids and phytosterols [6].  
Inflammation is a complex set of interactions that allow tissue to 
respond against injury or infection. It involves the participation of 
various cellular types expressing and reacting to diverse 
mediators along a very precise sequence of events [11]. Non 
steroidal anti inflammatory drugs (NSAIDs) are among the 
commonly used medications to treat pain and inflammatory 
conditions. However, due to undesirable side effects attributed to 
the prolonged use of NSAIDs and the ineffectiveness in some 
cases, the control of inflammatory pain is still a major challenge. 
Therefore, the search for more effective anti-inflammatory drugs is 
still very relevant.  Hence, the present study was aimed to 
evaluate the anti-inflammatory potential of ethanolic extract of 
Bauhinia purpurea bark in SD rats.  
Materials and methods 
Plant material and extract preparation 
The bark of Bauhinia pupurea was collected from lower slopes of 
Seshachalam hills, Tirupati, shade dried, coarsely powdered and 
extracted with ethanol as per I.P (Indian Pharmacopeia) 
guidelines for 7 days with intermittent shaking. The filtrate 
obtained was evaporated to dryness at 50-650C in a rotary 
vacuum evaporator to obtain a dark colored molten mass. The 
residue was stored in a refrigerator at 40C until use. 
Phytochemical analysis of ethanolic extract of Bauhinia purpurea 
was carried out to find the nature of bioactive compounds present 
[12]. 
Animals 
Experiments were conducted at Department of Biochemistry, Sri 
Venkateswara University, Tirupati, India. Adult Sprague Dawley 
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rats (190μ20 g) and standard normal diet were purchased from 
National Institute of Nutrition (NIN), Hyderabad, India. Rats were 
housed in polypropylene cages (photoperiod 12 h light/12 h dark 
cycle, 27μ30C, Humidity 30-60%). Animals were allowed to free 
access of diet and water ad libitum. Rats were acclimatized in 
laboratory condition for 7 days before performing experiments. All 
procedures involving laboratory animals were in accordance with 
the Institute Animal Ethics Committee regulations approved by the 
committee for the purpose of Control and Supervision of 
Experiments on Animals (CPCSEA).  Fasting was applied prior to 
all assays as standard drugs and plant extracts were administered 
orally. 
In vivo anti-inflammatory activity 
Acute toxicity studies 
The acute toxicity study of the plant extract (EBP) was performed 
with administration of two doses (1250 or 2500 mg/kg body 
weight). Rats were fasted for 12hr prior to the administration of 
plant extract. The animals in each group were observed for 2hr 
after treatment for immediate signs of toxicity. The mortality rate 
within 24hr was noted. Animals which survived were allowed free 
access to food and water and observed for over 5 days for signs 
of delayed acute toxicity including death [13].  
Carragenan induced paw edema 
Carragenan induced paw edema was produced according to the 
method of Winter et al (1962) with some modifications. Animals 
were divided in to five groups of six each, starved overnight with 
water prior to the day of experiments. Group-I was Carrageenan 
control, Group-II was Carrageenan+ Diclofenac treated, Group-III 
Carrageenan + EBP (200 mg /kg), Group-IV Carragenan + EBP 
(400 mg /kg) and Group-V Carragenan + EBP (600 mg /kg) 
treated. Left paw was marked with ink at the level of lateral 
malleolus, basal paw volume was measured plethysmo 
graphically by volume displacement method [14].  
The plant extract i.e, EBP or Diclofenac were administered orally 
one hour before injection of carrageenan. One hour after dosing, 
the rats were challenged by a subcutaneous injection of 0.1 ml of 
1 % solution of carrageenan in to the sub-plantar side of the left 
hind paw. The paw volume was measured again at 1, 2, 3, 4 and 
5 hr after challenge. The increase in paw volume was calculated 
as percentage compared with the basal volume. The difference of 
average values between the treated animals and control group 
was calculated for each time interval and evaluated statistically. 
The percentage inhibition was calculated using the formula as 
follows.  
% edema inhibition = [1-( Vt/ Vc)] x 100 
Vt and Vc are edema volume in the drug treated and control 
groups respectively. 
Induction of ear edema 
Rats were divided in to five groups of six each. Group-I was 
Arachidonic acid control, Group-II was Arachidonic acid+ 
Diclofenac treated, Group-III Arachidonic acid + EBP (200 mg 
/kg), Group-IV Arachidonic acid + EBP (400 mg /kg) and  Group-V 
Arachidonic acid + EBP (600 mg /kg) treated. Arachidonic acid 
(2mg /ear) was subcutaneously injected into the right ear of rats. 
Thickness of the ears was measured 1 hr before and 1,3 hr after 
the induction of  inflammation (Young et al.., 1987) using a digital 
caliper. The caliper was applied near tip of the ear just distal to 
the cartilaginous ridges and the thickness was recorded in øg. 
Edema was expressed as the increase in ear thickness due to the 
inflammatory challenge [15]. 
Carrageenan-induced air pouch inflammation in rats 
 The air pouch was created by injecting 20 ml of sterile air on day 
1st and 3rd . Group-1 was carrageenan control, Group -2 was 
carrageena + Diclofenace (10 mg/kg, p.o), Group -3 was 
carrageenan + EBP (200 mg/kg, p.o), Group- 4 was carrageenan 
+ EBP (400 mg/kg, p.o), Group-5 was carrageenan + EBP (600 
mg/kg). On 5 th day, 1 ml of 1% w/v carrageenan was injected to 
all the animals (except normal control) directly into the pouch. 
After 6hr, the animals were sacrificed and 5 ml of ice-cold saline 
was injected into the pouch and the exudates were collected. 
Total leukocyte and granulocyte count of lavage fluid was 
estimated using cell counter [16].     
Complete freundÊs adjuvant (CFA) induced hematological 
alterations in rats 
CFA (0.1 ml) was injected subplantar (each ml contains 1 mg of 
mycobacterium tuberculosis strain H37Ra), heat killed and dried, 
0.85 ml paraffin oil and 0.15 ml of mannide monooleate) procured 
from Sigma-Aldrich (Kalia et al., 2007). The rats were randomly 
divided into five groups viz., CFA control, DF (5mg/kg, p.o) 
treated, CFA + EBP (200 mg/kg, p.o) , CFA + EBP (400 mg/kg, 
p.o) and CFA + EBP (600 mg / kg, p.o) [17]. 
Motility Test 
The normal control rats which walked comfortably without any 
difficulty were given a score of 5, the carrageenan induced paw 
edema rats which walked with great difficulty, avoiding touching 
the toes of the inflamed paw to the floor scored 1. If the rats 
improved their walking ability because of administration of either 
diclofenac or EBP, they got scores between 1 and 5 [18-19]. 
Antioxidant assay 
The effect of EBP on DPPH radical was estimated following the 
method of Liyana-Pathirana and Shahidi (2005). A solution of 
0.135 mM DPPH in methanol was prepared and 1.0 ml of this 
solution was mixed with different concentrations of EBP (25, 50, 
100, 200, 400øg/ml). The reaction mixture was thoroughly shaken 
and left on the bench at room temperature for 30 min for complete 
reaction. The absorbance was measured at 517nm using a 
spectrophotometer. Ascorbic acid was used as standard. All 
determinations were done in triplicate. The ability of the sample to 
scavenge radicals was calculated by the following equation 
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DPPH radical scavenging activity (%) = absorbance control-
absorbance sample/absorbance of control X 100 [20]. 
Assessment of Lipid Peroxidation 
The liver tissue was collected and homogenised in 0.9% ice cold 
saline in teflon homogenizer. The homogenate was centrifuged at 
800g for 10 min and the supernatant was again centrifuged at 
12000 g for 15 min. The supernatant was used to measure the 
level of lipid peroxidation which was measured by the 
thiobarbituric acid (TBA) method [21]. 
Results 
Acute toxicity studies 
No abnormal behavior or death was noticed with rats 
administered with EBP of 1250 mg/kg body weight. However rats 
administered with EBP of 2500 mg/kg body weight showed 
restlessness, paw chewing for some time but became adjusted 
later. 
Carrageenan induced Paw edema 
 Administration of EBP, 1 hr before the injection of carrageenan 
caused a considerable and dose dependant inhibition of increase 
in paw edema in a time dependant manner as shown in figure-1. 
The inhibitory effect was almost 90% of the standard Diclofenac 
treatment.  
Arachidonic acid induced ear edema in rats 
There was about 20% increase in ear weight in arachidonic acid 
induced group of rats when compared to control group. In a 
concentration dependent fashion, EBP significantly inhibited ear 
edema caused by arachidonic acid. The alleviation in ear weight 
in the presence of EBP was 4-8%, while that of Diclofenac was 
only 3-5 % when compared to arachidonic acid controls (figure-2). 
This shows that plant extract is showing efficient anti-inflammatory 
effect against ear edema.  
Carrageenan induced air pouch inflammation in rats 
Carragenan caused raise in leucocytes and granulocytes counts 
in air pouch exudates. Treatment with EBP at doses of 200, 400 
and 600 mg/kg significantly and dose-dependently reduced total 
leukocytes count and granulocyte count in airpouch exudates 
when compared to carragenanan controls. EBP at 600 mg /kg 
showed similar results as that of Diclofenac (figure-3). 
CFA- induced Haematological alterations in rats  
CFA treatment enhanced WBC and ESR but reduced RBC and 
Hb per cent in experimental rats. However, EBP treatment 
significantly and dose-dependently restored the altered levels of 
the above parameters, the maximum effect being noticed with 600 
mg /kg of EBP (table-1). 
Motility test 
Walking ability of the rats to climb the staircase at the time of peak 
inflammation was checked by motility score. Carrageenan-
induced paw edema  rats scored 1, because they could walk with 
great difficulty, avoiding touching the toes of the inflamed paw to 
the floor. Diclofenac treatment attenuated the paw edema 
substantially and the rats walked with little difficulty and were 
scored 4. Treatment with 200 mg/kg, 400 mg/kg, 600mg/ kg 
bodyweight of EBP gradually reduced the paw edema and rats 
could improve their walk and scored 2, 3, 4 respectively. 
DPPH scavenging assay 
The scavenging effect of EBP and ascorbic acid on the DPPH 
radicals is illustrated in figure 4. With increasing concentration of 
EBP from 25-400øg/ml, significant and concentration dependent 
scavenging effect on the DPPH was noticed. At 400øg/ml, the 
activity of EBP was on par with ascorbic acid. 
Effect of EBP on lipid peroxidation 
Carragenan induced inflammation caused substantial increases in 
MDA levels indicating enhanced lipid peroxidation. Oral 
administration of EBP at three doses (200 mg, 400 mg and 600 
mg /kg body weight) resulted in significant and dose dependent 
decreases in LPO as evidenced by lowered MDA levels (figure-5). 
Discussion 
Carrageenan-induced rat paw edema is a prominent inflammatory 
model to evaluate anti-inflammatory effect of compounds. 
Inflammatory reactions are generally triggered off by exogenous 
or endogenous aggressions which are characterized by vascular 
and cellular events. These reactions play pivotal role in the 
expression of cyclooxygenases (COX) which enhance the 
production of inflammatory mediators such as leukotrienes and 
prostaglandins. Inflammation involves two phases of events. The 
first phase is due to release of histamine, serotonin and kinin like 
substance with in 3 hr and second accelerating phase of swelling 
is attributed to prostaglandins release after 3 hr. In our study, EBP 
(200, 400, and 600 mg/kg, p.o.) substantially reduced 
carrageenan induced paw edema in a dose dependent manner 
(fig-1). In carrageenan-induced air pouch inflammation, EBP 
significantly inhibited the cellular infilteration (neutrophils and 
granulocytes) in to the air pouch fluid (fig-3). Our results suggest 
that EBP possibly may have its inhibitory effect on the 
prostaglandin (PG) mediated inflammatory pathway or may act by 
inhibiting the release of histamine and serotonin [22]. 
 Study of arachadonic acid(AA) induced ear edema has been one 
of the sensitive tests for detecting the anti-inflammatory activity of 
lipoxygenase and cyclooxygenase inhibitors. Our results showed 
that EBP at concentrations of 400 mg /kg and above had 
attenuated the AA-induced ear edema to a great extent (fig-2). 
CFC-induced alterations in WBC, RBC counts, ESR and Hb per 
cent were substantially controlled by EBP treatments (table-1). 
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Reduction in Hb per cent and RBC count in inflammation could be 
due to decreased response of the erythropoietin and premature 
destruction of red blood cells. Elevated WBC levels are an 
indication of inflammation or infection. Erythrocyte sedimentation 
rate (ESR), is influenced by an increase in the plasma 
concentration of acute phase reactant proteins in response to the 
inflammation [23]. Our results showed that higher concentration of 
EBP (>400 mg/kg) had effectively normalized the CFC-induced 
hematological changes and thus confirmed its anti-inflammatory 
activity. 
The ability to walk and climb the staircase is considered as one of 
the critical tests to measure the intensity of paw edema and 
inflammation. In our study, with increase in the concentration of 
EBP, paw edema rats could improve their walking ability gradually  
 
Table.1 CFA induced haematological alterations in rats 
Treatment groups          Haemotological parameters 
               RBC (106ml/mm3)      WBC(X 103cell/mm3)     ESR (mm/h)      Hb(mg%)        
CFA control                7.96μ0.23                    12.98μ0.8                    13.76μ0.22        11.94μ0.54        
Diclofenac                     10.42μ0.38                   7.62μ0.37                      9.94μ0.34       16.14μ0.72 
EBP (200 mg/kg)           7.92μ0.19              11.42μ0.64                  13.12μ0.66       12.01μ0.92       
EBP (400 mg/kg)           8.59μ0.12                    10.36μ0.39                  12.12μ0.12       13.86μ0.49       
EBP (600 mg/kg)           9.26μ0.24                    7.91μ0.56                     10.44μ0.31      15.38μ0.83     
    
 
 
 Figure. 1 Carrageenan induced paw edema in rats 
The data are expressed as the meanμS.E.M (n=6). Values are statistically Significant at P < 0.05 
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 Figure.2 Arachidonic acid induced ear edema in rats 
The data are expressed as the meanμS.E.M (n=6). Values are statistically Significant at P < 0.05 
 
 
 Figure.3 Carragenan induced air pouch inflammation in rats 
 
The data are expressed as the meanμS.E.M (n=6). Values are statistically Significant at P < 0.05 
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Figure.4  DPPH Scavenging assay 
 
 
 
 
 
 Figure.5  Effect of EBP on lipid peroxidation in rats 
 
The data are expressed as the meanμS.E.M (n=6). Values are statistically Significant at P < 0.05 
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and at 600 mg /kg of EBP, they walked comfortably as evidenced 
by their achieved score 4 . 
In this study, the antioxidant activity of EBP was evaluated using 
the DPPH and lipid peroxidation assay methods. DPPH is a 
simple and effective method regularly used to assess the radical 
scavenging ability of plant extracts in vivo [24]. EBP showed 
potent antioxidant activity in a dose dependent manner as that of 
standard ascorbic acid (fig-4). The lipid peroxidation assay is an 
indication of oxidative stress induced damage of membranes. 
Estimation of MDA levels gives information on the free radical 
scavenging ability of the plant extract. Our results demonstrated 
that, carrageenan induced lipid peroxidation was considerably 
mitigated by treatment with EBP in a dose dependent manner (fig-
5). Together, our findings clearly demonstrated that, EBP has 
potent anti-inflammatory and antioxidant activity and provides 
scientific evidence for its use in folk and traditional medicine. 
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